twoXAR Pharmaceuticals is now ARIA Pharmaceuticals. Read More

News and Events Day: December 13, 2019

2019 saw tremendous growth for twoXAR. We launched nine new disease areas, expanding to new disease programs in our focus areas of ophthalmology, immunology & inflammatory, oncology and metabolic. We ended the year with eighteen total diseases in our portfolio, six of which have been out licensed.